1. Makurvet FD. Biologics vs. small molecules: drug costs and patient access. Med Drug Discov. 2021;9:100075.
2. US FDA. What are “Biologics” questions and answers. FDA; 2019 [cited 2022 Jul 14]. Available at: https://www.fda.gov/about-fda/center-biologics-evaluation-and-research-cber/what-are-biologics-questions-and-answers.
3. Doshi JA, Li P, Ladage VP, Pettit AR, Taylor EA. Impact of cost sharing on specialty drug utilization and outcomes: a review of the evidence and future directions. Am J Manag Care. 2016;22:188–97.
4. Lexchin J. Affordable biologics for all. JAMA Netw Open. 2020;3: e204753.
5. US FDA. Biosimilar and interchangeable products. FDA; 2019 [cited 2022 May 12]. Available at: https://www.fda.gov/drugs/biosimilars/biosimilar-and-interchangeable-products.